Showing results (2321-2330 of 6,777) with videos related to

Sort By:
Pageof 678
Clinical Therapeutics|December 6, 2007
Fabry disease model: a rational approach to the management of Fabry diseaseChristoph Wanner
Clinical Therapeutics|August 19, 2007
Dosing of insulin glargine in the treatment of type 2 diabetesAnthony Barnett
Clinical Therapeutics|August 19, 2007
A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhalerKevin Murphy, Michael Noonan, Philip E Silkoff, et al.
Clinical Therapeutics|August 19, 2007
Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokersMasakazu Nakamura, Akira Oshima, Yoko Fujimoto, et al.
Clinical Therapeutics|August 19, 2007
Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled studyAllan Gibofsky, Jude Rodrigues, Justus Fiechtner, et al.
Clinical Therapeutics|August 19, 2007
Retrospective analysis of electrocardiographic changes after administration of oral or intravenous garenoxacin in five phase I, placebo-controlled studies in healthy volunteersZaiqi Wang, Dennis M Grasela, Gopal Krishna
Clinical Therapeutics|August 19, 2007
A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumoniaMeghan N Jeffres, Warren Isakow, Joshua A Doherty, et al.
Clinical Therapeutics|August 19, 2007
Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy studyHumberto Quintana, Edward A Cherlin, David A Duesenberg, et al.
Clinical Therapeutics|August 19, 2007
Inhaled dry powder insulin for the treatment of diabetes mellitusStephen M Setter, Terri L Levien, Jason L Iltz, et al.
Clinical Therapeutics|August 19, 2007
Comparison of extended-release metformin in combination with a sulfonylurea (glyburide) to sulfonylurea monotherapy in adult patients with type 2 diabetes: a multicenter, double-blind, randomized, controlled, phase III studyAndrew Lewin, Robert Lipetz, Jacqueline Wu, et al.
Pageof 678